BSRBR-RA study blog

Latest blog posts from the study.

 

 

The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.

To find out more about the study, please visit our main site.

 

Latest blog posts

Switching from the original etanercept (the originator) to an etanercept biosimilar for rheumatoid arthritis (RA) โ€“ patients do just as well as those who remained on the originator.

Switching from the original etanercept (the originator) to an etanercept biosimilar for rheumatoid arthritis (RA) โ€“ patients do just as well as those who remained on the originator.

Researchers: Lianne Kearsley-Fleet, Aasiyah Rokad, Man-Fung Tsoi, Sizheng Steven Zhao, Mark Lunt, Kath D. Watson, BSRBR-RA Contributors Group, Kimme L. Hyrich. What was already known? Etanercept is one of the main treatment options for patients with rheumatoid...